SUMMARY Ninety three children (51 boys, 42 girls) who had been treated for brain tumours not affecting the hypothalamopituitary axis, were studied for evidence of gonadal dysfunction. All had received cranial irradiation, 59 spinal irradiation, and 28 adjuvant chemotherapy. Mean age at treatment was 6-3 years (range 1.5-15). Mean follow up after completion of radiotherapy was 8-5 years (range 1-27). Primary ovarian damage occurred in seven out of 11 (64%) girls treated with craniospinal irradiation alone and in nine out of 14 (64%) of those treated with craniospinal irradiation and chemotherapy. The association with spinal irradiation was significant. Primary gonadal damage also occurred in three out of four children treated with chemotherapy combined with cranial irradiation and in three out of nine boys treated with chemotherapy and craniospinal irradiation but in no boy given craniospinal irradiation alone. The only common chemotherapeutic agent was a nitrosurea. Hypogonadotrophic hypogonadism was found in seven boys, 5-8% of children of pubertal age.
Primary gonadal dysfunction is a well known complication of the treatment of some childhood malignancies, particularly leukaemia and lymphoma. '-8 The prevalence and aetiology of gonadal dysfunction after treatment of brain tumours in childhood are unclear; this is because reported series are relatively small and because of differences in treatment. Most authors have attributed gonadal damage to scatter from spinal irradiation9 10 but more recently Ahmed et al concluded that adjuvant chemotherapy was responsible.' Brown et al also referred to girls with primary ovarian damage after treatment with lomustine (CCNU) without spinal irradiation.'0) Three affected girls with ovarian damage attributed to spinal irradiation, described by RapVaport et al, had also received chemotherapy.
Gonadal dysfunction can also be secondary to gonadotrophin deficiency caused by cranial irradiation 9 12 but there are few data on the incidence after the treatment of childhood brain tumours. Rappaport et al reported that gonadotrophin deficiency may occur infrequently in these patients.9
We have studied the aetiology and prevalence of primary and secondary gondal dysfunction in a large cohort of children treated for brain tumours.
Patients and methods
Altogether 125 dysfunction in these girls. The relatively few studies of ovarian function after abdominal or spinal irradiation in childhood show that ovaries are vulnerable to damage at any age.2 Our data support this but show an increased prevalance among younger girls, which may indicate that the ovary is more vulnerable but which is more probably due to the greater mobility of the ovarian position in relation to the spinal field.
Ovarian dysfunction was not a consistent complication of spinal irradiation, as others have shown.i9u The likely explanation is provided by serial pelvic ultrasound scans that show that ovaries move frequently, particularly in a lateral plane (J Adams, Middlesex Hospital, personal communication). This observation may have implications for the prevention of ovarian damage, suggesting that only adequate surgical transposition (oophoropexy) will reduce the incidence of radiation induced damage. Oophoropexy has been shown to reduce the incidence of amenorrhoea in adult women after irradiation for Hodgkin's disease. ' given in combination with spinal irradiation so data about its independent effect are few. In this study lomustine was the only cytotoxic agent common to children with primary gonadal dysfunction not associated with spinal irradiation. This supports the conclusion of Ahmed et all' that nitrosureas are gonadotoxic but our data indicate that the effects of spinal irradiation are more important than was suggested in that study. This may be due to the much larger number of children in our series but also possibly to the differences in spinal irradiation techniques used. In the Manchester study of Ahmed et al, the spinal radiation beam was directed medially towards the spine while in our patients the beam was perpendicular to the skin. There were no differences in fractionation. If these differences in outcome are substantiated, modifications in radiation technique might be justified.
There is controversy about the sensitivity of prepubertal gonads to damage by chemotherapy3 5 16 and the relative sensitivity of testes and ovaries to damage by chemotherapy or radiotherapy. 17 Few children received chemotherapy alone but the affected girls were prepubertal, and there were equal numbers of affected prepubertal and pubertal boys.
Gonadotrophin deficiency not explained by the tumour site was rare at the median follow up of 8-5 years. Hypopituitarism is known to evolve up to 10 years after similar doses of irradiation for pituitary tumours, (40-50 Gy),'8 so ours may be an underestimate. No relation with radiation dose was seen but the dose range was relatively narrow. This is the largest reported study of gonadal dysfunction in this group of patients and shows that primary gonadal dysfunction was not uncommon particularly after gonadal radiation or certain cytotoxics whereas secondary gonadal dysfunction was rare. Long term endocrine follow up of these children is clearly required of the centres treating them. As survival improves the complications of treatment are found more often and should be considered when devising new treatment regimens. 
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